What is the difference between Lttl’s compounded medications and brand-name Ozempic, Wegovy, or Mounjaro?

Ozempic, Wegovy, and Mounjaro are brand-name medications that have been reviewed and approved by the FDA for specific indications. Lttl offers compounded versions of the same active ingredients - semaglutide and tirzepatide - prepared by licensed U.S. compounding pharmacies. Key differences:

• Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
• Compounded formulations are prepared by licensed compounding pharmacies, not manufactured by the original brand.
• Compounded medications may differ in formulation, inactive ingredients, concentration, or delivery device from brand-name products.
• Lttl’s compounded medications are prescribed by licensed providers and prepared to individualized specifications.

If you have questions about whether a compounded medication is right for you versus a brand-name alternative, discuss this with your provider during your clinical evaluation.